![Italian Medicines Agency](https://www.aifa.gov.it/o/aifa-theme/images/aifa/AIFA2021_Col(LR).png)
Monitoring of monoclonal antibodies for COVID-19: weekly report published - Monitoring of monoclonal antibodies for COVID-19: weekly report published
Monitoring of monoclonal antibodies for COVID-19: weekly report published
![](/documents/20142/1558088/I_anticorpi_monoclonali_03.jpeg/73350874-b614-4182-1d81-603e86b37c0b?t=1630423282045)
AIFA publishes the results of the monitoring related to monoclonal antibodies for the treatment of COVID-19 currently available. The monitoring is carried out through the AIFA Register developed in implementation of the Decree of the Ministry of Health of 6 February 2021 (published in the Italian Official Journal general series no. 32 of 8/2/21).
The centres enabled by the Regions to fill in the AIFA Register are available on the page "Centres enabled mAb COVID-19" accessible from the box "Related links".
Published on: 08 April 2022